Scientific Advisory Board
The Scientific Advisory Board is a multi-disciplinary international board with expertise in broad areas of technology. This Board focuses on further developing key technologies and applications in the life sciences. Its members are leading experts in a diverse range of life science areas, which include cell therapy processing, cell line engineering, stem cells, cell analytics and biosensors.
“The unbiased advice of the Scientific Advisory Board supports Sartorius in maintaining a diverse, external view of trends in the industry and in guiding Sartorius' technological initiatives.”
Oscar-Werner Reif, Head of Corporate Research, CTO
Members
Shana O. Kelley
Professor at Department Biomaterials & Biomedical Engineering, University of Toronto, Canada
"Bringing a new technology to market is a huge challenge – and many have failed trying. So you have to be prepared for skeptics. Believing 100 percent in what you're doing ... is key."
(Source: https://theglobeandmail.com/report-on-business/innovators-at-work/a-quicker-way-of-diagnosing-diseases/article18762485)
Mark Lowdell
Professor of Cell & Tissue Therapy, Director of Centre for Cell Gene & Tissue Therapeutics, Royal Free London FT, UK
“I am delighted and excited to join the Scientific Advisory Board at a time when the expertise and resources of Sartorius are becoming ever more relevant to the field of clinical cell and gene therapy development.”
Christine Mummery
Professor of Developmental Biology and Chair of the Department of Anatomy and Embryology, Leiden University Medical Center, Netherlands
"I love science, and I find it fascinating, I like the excitement of learning new things, meeting new people and ideas and getting feedback all the time."
(Source: https://pharmaboardroom.com/interviews/interview-christine-mummery-professor-of-developmental-biology-and-chair-of-the-department-of-anatomy-and-embryology-leiden-university-medical-center-the-netherlands)
Thomas Scheper
Professor of Technical Chemistry, former Head of the Institute of Technical Chemistry at the Leibniz University of Hannover, Germany
"We are now entering a new era in biotechnology where digitalization is set to be a game changer for the field. Cells and biomolecules will be designed from scratch in silico. Artificial intelligence and machine learning have the potential to disrupt and reshape biotechnology with exciting perspectives for the future of the field."
Yoav Shechtman
Associate Professor at the Department of Biomedical Engineering and Lokey Interdisciplinary Center for Life Sciences & Engineering, Technion Israel Institute of Technology, Israel
“I really got exposed to the world of biology and I was fascinated by this world. I chose to take my knowledge from engineering and apply it to answer the [...] most burning questions nowadays in biology“
(Source: https://youtu.be/xgE7XXPP3J4)
